日本語English简体中文 繁體中文

600276 Jiangsu Hengrui Pharmaceuticals恒瑞医药Shanghai Stock Exchange

16 posts

Jiangsu Hengrui Pharmaceuticals (600276) at a glance

Code
600276
Company
Jiangsu Hengrui Pharmaceuticals
Local name
恒瑞医药
Market
Shanghai Stock Exchange
Share price
CN¥46.00 -1.38 (-2.91%) Oct 22 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Jiangsu Hengrui Pharmaceuticals (600276) Stock Price History

Jiangsu Hengrui Pharmaceuticals closed at CN¥46.00 on Oct 22, 2026, +0.6% over 1 month, −29.5% over 1 year.

2026-09-22 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-24 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-25 株主総会 恒瑞医药2026年第一次临时股东会法律意见书 / 株主総会決議 恒瑞医药2026年第一次临时股东会决议公告2026-09-29 契約の締結 恒瑞医药关于与Novo Nordisk A/S签署HRS-1596项目授权许可协议的公告2026-10-09 新薬・製品の承認 恒瑞医药关于药品上市许可申请获EMA受理的提示性公告 / 自社株買い 恒瑞医药关于回购公司A股股份的进展公告2026-10-14 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-10-15 取締役会 H股公告-董事会会议通告CN¥47.45CN¥44.47Sep 22Oct 22
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥47.45Oct 20
1-Month LowCN¥44.47Sep 28
1-Week Change−1.3%vs Oct 15
1-Month Change+0.6%vs Sep 22

If you had invested CN¥10,000 1 month ago, it would be worth CN¥10,061 today (+0.6%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −6.0%, while this stock moved +0.6%.

Last 10 Trading Days

DateCloseChange% Change
Oct 22 (Thu)CN¥46.00−1.38−2.91%
Oct 21 (Wed)CN¥47.38−0.07−0.15%
Oct 20 (Tue)CN¥47.45+1.37+2.97%
Oct 19 (Mon)CN¥46.08−0.55−1.18%
Oct 16 (Fri)CN¥46.63+0.03+0.06%
Oct 15 (Thu)CN¥46.60+1.11+2.44%
Oct 14 (Wed)CN¥45.49−0.02−0.04%
Oct 13 (Tue)CN¥45.51−0.54−1.17%
Oct 12 (Mon)CN¥46.05−0.80−1.71%
Oct 9 (Fri)CN¥46.85−0.16−0.34%
2026-09-15 新薬・製品の承認 恒瑞医药关于药品上市许可申请获受理的提示性公告2026-09-16 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-18 自社株買い 恒瑞医药关于首次回购公司A股股份的公告2026-09-19 株主総会 恒瑞医药2026年第一次临时股东会会议资料2026-09-22 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-24 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-25 株主総会 恒瑞医药2026年第一次临时股东会法律意见书 / 株主総会決議 恒瑞医药2026年第一次临时股东会决议公告2026-09-29 契約の締結 恒瑞医药关于与Novo Nordisk A/S签署HRS-1596项目授权许可协议的公告2026-10-09 新薬・製品の承認 恒瑞医药关于药品上市许可申请获EMA受理的提示性公告 / 自社株買い 恒瑞医药关于回购公司A股股份的进展公告2026-10-14 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-10-15 取締役会 H股公告-董事会会议通告CN¥55.39CN¥42.67Jul 22Oct 22
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥55.39Jul 22
3-Month LowCN¥42.67Sep 11
1-Month Change+0.6%vs Sep 22
3-Month Change−17.0%vs Jul 22

If you had invested CN¥10,000 3 months ago, it would be worth CN¥8,305 today (−17.0%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −4.0%, while this stock moved −17.0%.

Last 10 Trading Days

DateCloseChange% Change
Oct 22 (Thu)CN¥46.00−1.38−2.91%
Oct 21 (Wed)CN¥47.38−0.07−0.15%
Oct 20 (Tue)CN¥47.45+1.37+2.97%
Oct 19 (Mon)CN¥46.08−0.55−1.18%
Oct 16 (Fri)CN¥46.63+0.03+0.06%
Oct 15 (Thu)CN¥46.60+1.11+2.44%
Oct 14 (Wed)CN¥45.49−0.02−0.04%
Oct 13 (Tue)CN¥45.51−0.54−1.17%
Oct 12 (Mon)CN¥46.05−0.80−1.71%
Oct 9 (Fri)CN¥46.85−0.16−0.34%
2026-09-15 新薬・製品の承認 恒瑞医药关于药品上市许可申请获受理的提示性公告2026-09-16 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-18 自社株買い 恒瑞医药关于首次回购公司A股股份的公告2026-09-19 株主総会 恒瑞医药2026年第一次临时股东会会议资料2026-09-22 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-24 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-25 株主総会 恒瑞医药2026年第一次临时股东会法律意见书 / 株主総会決議 恒瑞医药2026年第一次临时股东会决议公告2026-09-29 契約の締結 恒瑞医药关于与Novo Nordisk A/S签署HRS-1596项目授权许可协议的公告2026-10-09 新薬・製品の承認 恒瑞医药关于药品上市许可申请获EMA受理的提示性公告 / 自社株買い 恒瑞医药关于回购公司A股股份的进展公告2026-10-14 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-10-15 取締役会 H股公告-董事会会议通告CN¥57.50CN¥42.67Apr 22Oct 22
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥57.50Jul 15
6-Month LowCN¥42.67Sep 11
3-Month Change−17.0%vs Jul 22
6-Month Change−17.0%vs Apr 22

If you had invested CN¥10,000 6 months ago, it would be worth CN¥8,297 today (−17.0%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −9.6%, while this stock moved −17.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026CN¥46.00−2.5%
Sep 2026CN¥47.20+2.5%
Aug 2026CN¥46.07−14.8%
Jul 2026CN¥54.08+3.9%
Jun 2026CN¥52.04+3.7%
May 2026CN¥50.19−6.8%
Apr 2026CN¥53.88−2.4%
2026-09-15 新薬・製品の承認 恒瑞医药关于药品上市许可申请获受理的提示性公告2026-09-16 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-18 自社株買い 恒瑞医药关于首次回购公司A股股份的公告2026-09-19 株主総会 恒瑞医药2026年第一次临时股东会会议资料2026-09-22 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告 / 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-24 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-09-25 株主総会 恒瑞医药2026年第一次临时股东会法律意见书 / 株主総会決議 恒瑞医药2026年第一次临时股东会决议公告2026-09-29 契約の締結 恒瑞医药关于与Novo Nordisk A/S签署HRS-1596项目授权许可协议的公告2026-10-09 新薬・製品の承認 恒瑞医药关于药品上市许可申请获EMA受理的提示性公告 / 自社株買い 恒瑞医药关于回购公司A股股份的进展公告2026-10-14 新薬・製品の承認 恒瑞医药关于获得药物临床试验批准通知书的公告2026-10-15 取締役会 H股公告-董事会会议通告CN¥67.01CN¥42.67Oct 22Oct 22
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥67.01Oct 27
52-Week LowCN¥42.67Sep 11
Year to Date−22.8%vs Dec 31
From 52-Week High−31.4%Oct 27

If you had invested CN¥10,000 1 year ago, it would be worth CN¥7,049 today (−29.5%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −5.1%, while this stock moved −29.5%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026CN¥46.00−2.5%
Sep 2026CN¥47.20+2.5%
Aug 2026CN¥46.07−14.8%
Jul 2026CN¥54.08+3.9%
Jun 2026CN¥52.04+3.7%
May 2026CN¥50.19−6.8%
Apr 2026CN¥53.88−2.4%
Mar 2026CN¥55.22−2.4%
Feb 2026CN¥56.56−2.8%
Jan 2026CN¥58.16−2.4%
Dec 2025CN¥59.57−4.0%
Nov 2025CN¥62.08−3.2%
Oct 2025CN¥64.15―
CN¥72.47CN¥35.95Oct 23, 2023Oct 22, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥72.47Sep 1, 2025
3-Year LowCN¥35.95Jan 29, 2024
Annualized Return+0.4%
Max Drawdown−41.1%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥10,132 today (+1.3%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +23.0%, while this stock moved +1.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥46.00−22.8%
2025CN¥59.57―
CN¥72.47CN¥29.34Oct 25, 2021Oct 22, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥72.47Sep 1, 2025
5-Year LowCN¥29.34May 2, 2022
Annualized Return−1.4%
Max Drawdown−44.2%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥9,342 today (−6.6%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +4.7%, while this stock moved −6.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥46.00−22.8%
2025CN¥59.57―
CN¥92.88CN¥0.26Nov 1, 2000Oct 22, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥92.88Dec 2020
All-Time LowCN¥0.26Sep 2003
Total Change+7,490.8%vs Nov 2000
Annualized Return+18.1%

If you had invested CN¥10,000 in Nov 2000, it would be worth CN¥759,076 today (+7,490.8%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +79.3%, while this stock moved +7,490.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥46.00−22.8%
2025CN¥59.57+29.8%
2024CN¥45.90+1.5%
2023CN¥45.23+17.4%
2022CN¥38.53−24.0%
2021CN¥50.71−45.4%
2020CN¥92.88+52.8%
2019CN¥60.78+99.1%
2018CN¥30.53−0.6%
2017CN¥30.71+81.9%
2016CN¥16.88+11.2%
2015CN¥15.19+70.4%
2014CN¥8.91+8.6%
2013CN¥8.21+38.8%
2012CN¥5.92+12.5%
2011CN¥5.26−25.9%
2010CN¥7.09+36.1%
2009CN¥5.21+63.6%
2008CN¥3.19−18.5%
2007CN¥3.91+128.4%
2006CN¥1.71+255.5%
2005CN¥0.48+18.2%
2004CN¥0.41+48.5%
2003CN¥0.27−16.5%
2002CN¥0.33−28.9%
2001CN¥0.46−26.9%
2000CN¥0.63―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Nov 2000). Please check the latest prices before trading.

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.16 Disclosure 2026/10/15 09:00
取締役会
H股公告-董事会会议通告
Delete
No.15 Disclosure 2026/10/14 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.14 Disclosure 2026/10/09 09:00
自社株買い
恒瑞医药关于回购公司A股股份的进展公告
Delete
No.13 Disclosure 2026/10/09 09:00
新薬・製品の承認
恒瑞医药关于药品上市许可申请获EMA受理的提示性公告
Delete
No.12 Disclosure 2026/09/29 09:00
契約の締結
恒瑞医药关于与Novo Nordisk A/S签署HRS-1596项目授权许可协议的公告
Delete
No.11 Disclosure 2026/09/25 09:00
株主総会決議
恒瑞医药2026年第一次临时股东会决议公告
Delete
No.10 Disclosure 2026/09/25 09:00
株主総会
恒瑞医药2026年第一次临时股东会法律意见书
Delete
No.9 Disclosure 2026/09/24 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.8 Disclosure 2026/09/22 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.7 Disclosure 2026/09/22 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.6 Disclosure 2026/09/22 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.5 Disclosure 2026/09/19 09:00
株主総会
恒瑞医药2026年第一次临时股东会会议资料
Delete
No.4 Disclosure 2026/09/18 09:00
自社株買い
恒瑞医药关于首次回购公司A股股份的公告
Delete
No.3 Disclosure 2026/09/16 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.2 Disclosure 2026/09/16 09:00
新薬・製品の承認
恒瑞医药关于获得药物临床试验批准通知书的公告
Delete
No.1 Disclosure 2026/09/15 09:00
新薬・製品の承認
恒瑞医药关于药品上市许可申请获受理的提示性公告
Delete

Write on the Jiangsu Hengrui Pharmaceuticals board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English